शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
SAILIFENSESai Life Sciences Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Thu, 5 Feb, 2026 · 21:34 IST

Sai Life Sciences Q3 PAT up about 86% YoY, revenue grows about 27%

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionExceptional ItemResults View source PDFExplain this filing

SAILIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+4.4%Reaction day
₹811.00
prior close
₹851.00
announcement price
After-mkt
timing
Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-0.3%+4.8% vs market
Pharmaceuticals peers, median of 159sector-0.6%+5.1% vs sector

On the reaction day the stock moved 4.8 pts more than Nifty Smallcap 250 and 5.1 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.4
10m
+2.3
15m
+0.5
30m
-0.8
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+4.4-0.3+4.8-0.6+5.1
Next day
+10.1+2.2+7.9+1.1+9.0
2d
+13.1+2.7+10.4+1.7+11.4
3d
+16.4+2.8+13.6+1.3+15.1
4d
+14.3+2.1+12.2+0.5+13.8
5d
+13.1+0.4+12.6+0.0+13.0
1w
+15.3+1.1+14.2-0.2+15.4
15d
+23.2-0.2+23.4-2.7+25.9
1m
+28.2-3.1+31.3-4.6+32.8
2m
+16.5-6.5+23.0-7.4+23.9
3m
+33.2+8.3+24.9+2.6+30.6
UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 159Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Sai Life Sciences posted Q3 FY26 consolidated revenue of Rs 5,564.64 million, up 26.5% YoY, with PAT at Rs 1,003.75 million, up 86% YoY. For 9M FY26, consolidated revenue rose 42.6% to Rs 15,903.53 million and PAT nearly tripled to Rs 2,446.74 million. Standalone 9M revenue grew 45% and PAT rose 186%. An exceptional loss of Rs 82.93 million was booked for the new Labour Codes wage impact. Deloitte issued an unmodified review.

Likely market impact

Strong top-line and earnings growth with margin expansion; one-time Labour Code charge is a minor drag. Overall positive.